findmyKOL

Stanley Jordan, MD

Enriched profile

Director of Nephrology, Medical Director of the Kidney Transplant Program, and Director of Pediatric Nephrology and Transplant Immunology at Cedars-Sinai Medical Center · Cedars-Sinai Medical Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 West Hollywood, CA · West · United StatesSpecialtyNephrologyFocusRenal Transplantation Outcomes and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2021–2025NIH funding1985–2026

Stanley Jordan is Director of Nephrology, Medical Director of the Kidney Transplant Program, and Director of Pediatric Nephrology and Transplant Immunology at Cedars-Sinai Medical Center at Cedars-Sinai Medical Center. OpenAlex indexes 486 publications with 19,751 citations (h-index 75); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.

Data verified 18 Oct 2026

Overview

Updated 18 Oct 2026

Stanley Jordan, MD, is Director of Nephrology, Medical Director of the Kidney Transplant Program, and Director of Pediatric Nephrology and Transplant Immunology at Cedars-Sinai Medical Center. The public record shows 486 publications with 19,751 citations (h-index 75), centered on Renal Transplantation Outcomes and Treatments, Transplantation: Methods and Outcomes, Organ Donation and Transplantation. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 14 companies, 10 NIH-funded awards (1985–2026).

  • Most recent indexed publication: 2026 · Journal of the American Society of Nephrology
  • Top research focus: Renal Transplantation Outcomes and Treatments
  • 11 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 14 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Renal Insufficiency3 trialsESRD / Dialysis3 trialsReperfusion Injury1 trialDelayed Graft Function1 trial

Research focus

OpenAlex concept fingerprint
Renal Transplantation Outcomes and TreatmentsTransplantation: Methods and OutcomesOrgan Donation and TransplantationT-cell and B-cell ImmunologyOrgan and Tissue Transplantation Research

Drugs & molecules

across trials, industry payments and publications
Empaveligeneric · PegcetacoplanClinical trials—Industry payments4Publications—NULOJIXClinical trials—Industry payments4Publications—Krystexxageneric · PegloticaseClinical trials—Industry payments2Publications—Thymoglobulingeneric · Lymphocyte immune globulin, anti-thymocyte globulinClinical trials—Industry payments2Publications—Vyvgartgeneric · Efgartigimod alfaClinical trials—Industry payments2Publications—Vyvgart Hytrulogeneric · Efgartigimod alfa / hyaluronidaseClinical trials—Industry payments2Publications—ATGAMClinical trials—Industry payments1Publications—Envarsusgeneric · TacrolimusClinical trials—Industry payments1Publications—Uvadexgeneric · MethoxsalenClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
CSL BehringClinical trials—Industry payments20Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments15Argenx Us, Inc.Clinical trials—Industry payments10Sanofi-Aventis U.S. LLCClinical trials—Industry payments8Apellis Pharmaceuticals, Inc.Clinical trials—Industry payments6Mallinckrodt Hospital Products Inc.Clinical trials—Industry payments6Cedars-Sinai Medical CenterClinical trials4Industry payments—E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments4Stanley Jordan, MDClinical trials4Industry payments—National Institute of Allergy and Infectious Diseases (NIAID)Clinical trials3Industry payments—Horizon Therapeutics plcClinical trials—Industry payments2Biogen, Inc.Clinical trials—Industry payments1Genzyme CorporationClinical trials—Industry payments1Pfizer Inc.Clinical trials—Industry payments1Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments1Veloxis Pharmaceuticals, Inc.Clinical trials—Industry payments1Vertex Pharmaceuticals IncorporatedClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
486publications

Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.

19,751citations

Total citations across indexed works.

75h-index

Hirsch index (OpenAlex). i10-index 268.

Clinical & industry

trials, payments and federal funding
11clinical trials

Investigator role on registered studies.

View trials ↓
14companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
10NIH grants · 1985–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:

All 11 trial records: search, sort and filter.Explore →

Industry payments

Updated 18 Oct 2026

14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 24 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    54.8%
    Corticosteroid48.9%
    Prednisone100%
    Part D≥33 patients
    Vitamin D3 Analog5.9%
    Calcitriol100%
    Part D<11 patients

  • Anti-infectives

    21.4%
    Azole Antifungal7.4%
    Fluconazole100%
    Part D<11 patients
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor6.5%
    Valacyclovir100%
    Part D≥12 patients

    + 2 more classes in this area

  • Cancer & immunology

    19.5%
    Calcineurin inhibitor11.1%
    Tacrolimus100%
    Part D<11 patients
    Selective T Cell Costimulation Blocker8.4%
    Nulojix100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)11.6% facility · 88.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

10 NIH research awards on record, funded 1985–2026 per NIH RePORTER. The latest:

All 25 award records: search, sort and filter.Explore →

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 17 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
    Article692 citations2008
    doi.org ↗
  2. 02
    Update on the use of immunoglobulin in human disease: A review of evidence
    Article666 citations2016
    doi.org ↗
  3. 03
    Cell-Free DNA and Active Rejection in Kidney Allografts
    Article584 citations2017
    doi.org ↗
  4. 04
    1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.
    Article508 citations1984
    doi.org ↗
  5. 05
    National Conference to Assess Antibody-Mediated Rejection in Solid Organ Transplantation
    Article455 citations2004
    doi.org ↗
All 486 cited works: search, sort and filter.Explore →

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Ashley A. Vo167Mieko Toyoda129Alice Peng63Edmund Huang54Jua Choi45Joseph M. Kahwaji41Dechu P. Puliyanda40Shili Ge36Noriko Ammerman34James Mirocha32Asha Moudgil27Reiad Najjar26Lawrence S.C. Czer26Irene K. Kim26Richard Ν. Fine26Robert B. Ettenger24Mark Haas24Nancy L. Reinsmoen23Supreet Sethi22Xiao-Jing Zuo22Suphamai Bunnapradist21Rebecca S. Sakai21Gordon D. Wu21Hui‐Kim Yap20Cynthia C. Nast20Alberto Mario Marchevsky19Robert A. Montgomery19Jack M. Matloff19Bongha Shin19N. Chai18Andy Pao17Yoshinori Okada17Xiaohai Zhang16Alfredo Trento16Rafael Villicana16Dolly B. Tyan15I. Kim14Chih‐Hung Lai14Artur Karasyov13Helen P. Pizzo13

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    ast.digitellinc.com/ast/speakers/view/1286

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ast.digitellinc.com ↗
  • Other

    cedars-sinai.org/newsroom/cedars-sinai-transplant-immunology-innovator-earns-top-distinction

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cedars-sinai.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Associate

    Association of American Physicians

    2022
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newswise.com ↗
  • Fellow

    American Society of Transplantation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ast.digitellinc.com ↗
  • Fellow

    American Society of Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ast.digitellinc.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.